Myosin binding protein - C (MyBPC) is a multi-domain protein whose role in the sarcomere is complex and not yet fully understood. The cardiac isoform is linked to familial hypertrophic cardiomyopathy (FHC), which is caused by the expression of abnormal sarcomeric proteins, including numerous mutations in MyBPC. The core structure of cardiac MyBPC consists of eight immunoglobulin (IgI) and three fibronectin (FnIII) domains, numbered 0 - 10 from the N-terminus. The C-terminus of MyBPC binds to titin and the myosin backbone and may bind other MyBPC molecules. At its N-terminus, MyBPC binds myosin S2 when dephosphorylated and may bind the myosin head and actin. MyBPC is phosphorylated up to 3 times in the linker between IgI domains 1 and 2, causing dissociation from S2 and increased contractile force. The role of partial phosphorylation remains unclear. The N-terminal construct, C1C2 (two IgI domains linked by the phosphorylatable linker), has been cloned, expressed, and purified. FHC and permanently phosphorylated mutants have also been produced. The constructs were studied by modelling, circular dichroic (CD) spectroscopy and myosin binding assays. Modelling of the C1C2 construct suggests an alpha-helical content within the phosphorylation linker region. CD spectra confirmed that a fraction of the protein is indeed alpha-helix. CD spectral changes for several FHC mutants indicate secondary structural change. C1C2 binding to myosin was confirmed using a sedimentation assay. Surprisingly, C1C2 also binds to actin, but only in its filamentous form, and this binding appears to be phosphorylation dependent.